GARY SENDER

Profile

First Name

: GARY

Middle Name

:

Last Name

: SENDER

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
NABRIVA THERAPEUTICS PLC
AXEL BOLTE, CARRIE BOURDOW, COLIN BROOM, DANIEL BURGESS, MARK CORRIGAN, ROBERT CROTTY, STEVEN GELONE, FRANCESCO MARIA LAVINO, CHARLES A. ROWLAND, JENNIFER SCHRANZ, THEODORE SCHROEDER, GEORGE H. TALBOT, STEPHEN WEBSTER
DIRECTOR
GENNAO BIO, INC.
BRADLEY CAMPBELL, CHRIS DUKE, CRAIG GORDON, ANUJ GOSWAMI, JULIE HAMBLETON, CHAU KHUONG, DALE LUDWIG, JOE MCINTOSH, CLAUDINE PROWSE, STEPHEN SQUINTO, PETER THOMPSON, BRUCE TURNER
DIRECTOR
ELUCIDA ONCOLOGY, INC.
GREGORY ADAMS, ELIEL BAYEVER, ISAAC BLECH, TIM BORIS, MICHELLE BRADBURY, ROBERT ESSNER, ROBERT A. ESSNER, GENO GERMANO, SOMAIYA IAN, STEVEN LARSON, KAI MA, NATALIE MACDONALD, SIGURDUR OLAFSSON, TERESA RESSEL, TERESA M. RESSEL, EDWARD ROSEN, ROBERT RUFFOLO, ROBERT A. RUFFOLO, MICHAEL SMITH, MICHAEL T. SMITH, ULRICH WIESNER, DAVID ZACARDELLI
DIRECTOR
IBIO, INC.
DAVID ARKOWITZ, LINDA ARMSTRONG, MARC BANJAK, PAMELA BASSETT, MARTIN BRENNER, MARTIN A. BRENNER, GLENN CHANG, WILLIAM CLARK, FELIPE DURAN, ARTHUR ELLIOTT, ROBERT ERWIN, SEYMOUR FLUG, MARK GIANNONE, JAMES HILL, JAMES T. HILL, ROBERT KAY, ALEXANDRA KROPOTOVA, ALEXANDRA KROPTOVA, FREDERICK LARCOMBE, JOHN MCKEY, JOHN D MCKEY, ANTONIO PARADA, PHILIP RUSSELL, PHILIP K. RUSSELL, TERENCE RYAN, GEOFFREY SCHILD, EVERT SCHIMMELPENNINK, GARY SENDE, EVERT SHIMMELPENNINK
DIRECTOR
APNIMED, INC.
JOSEPH AVELLONE, JOSEPH C. AVELLONE, FRANCOIS BEAUBIEN, RAMZI BENAMAR, GERALD CHAN, ISAAC CHENG, ISAAC C. CHENG, CHRIS DIMITROPOULOS, CHRIS C. DIMITROPOULOS, RON FARQUHAR, PAUL FONTEYNE, JAMES GALEOTA, ROSY HU, RUOXI HU, STEFAN LARSON, KEVIN C. LIND, LAWRENCE MILLER, LAWRENCE G. MILLER, DENNIS MOLNAR, DENNIS C. MOLNAR, MICHAEL ROGERS, BARRY WOHL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-03-11 
2026-01-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-01-08 
2025-12-08
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-09-17 
2025-10-01
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-09-17 
2025-09-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-09-17 
2025-05-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-04-29 
2025-04-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-04-23 
2023-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-08-04 
2023-08-03
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2023-05-24 
2023-06-15
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-05-24 
2022-12-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-28 
2022-03-28
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2022-03-11 
2021-12-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-06 
2018-07-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2018-07-24